Using virtual reality and music to help breast cancer patients during chemotherapy
VRtuose (Virtual RealiTy and mUsic in the Oncology SEtting) : A Single-centre Feasibility Study Evaluating a Strategy Combining Virtual Reality and Music to Improve Quality of Life in Breast Cancer Patients Undergoing Chemotherapy
This study is testing whether using virtual reality and music can help breast cancer patients feel less anxious and uncomfortable during their chemotherapy treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | International Agency for Research on Cancer Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Lyon) |
| Trial ID | NCT06305117 on ClinicalTrials.gov |
What this trial studies
The VRtuose project aims to assess the feasibility of a distraction strategy that combines virtual reality and music for breast cancer patients undergoing chemotherapy. This non-randomized, single-center feasibility study will take place at the Centre Léon Bérard in Lyon, where participants will receive the intervention during their chemotherapy sessions. The study will evaluate the impact of this approach on patients' anxiety, pain, nausea, mood disturbances, and overall quality of life. All eligible women will be offered the intervention throughout their chemotherapy course.
Who should consider this trial
Good fit: Ideal candidates are women diagnosed with breast cancer who are about to start or are currently receiving chemotherapy.
Not a fit: Patients with conditions that contraindicate the use of virtual reality, such as epilepsy or severe motion sickness, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for breast cancer patients during chemotherapy by reducing anxiety and pain.
How similar studies have performed: While the combination of virtual reality and music is a novel approach in this specific context, similar studies have shown promising results in using distraction techniques to improve patient experiences.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histologically confirmed diagnosis of breast cancer; * Any disease stage; * Patient must be receiving (i.e., with at least 4 remaining cures) or about to start palliative or curative neoadjuvant or adjuvant chemotherapy for their breast cancer at Centre Léon Bérard; * Willingness and ability to comply with the study requirements; * Patient must be covered by a medical insurance; * Patient must understand, speak, read and write French. Exclusion Criteria: * History of condition contraindicating the use of virtual reality (e.g., epilepsy, severe motion sickness); * Brain metastases; * Any medical or psychosocial condition that would compromise the patient's compliance to the study procedures or would likely interfere with the completion of Patient-Reported Outcomes; * Patients under tutorship or curatorship; * Patients already included in another clinical trial ongoing at Centre Léon Bérard.
Where this trial is running
Lyon
- Centre Léon Bérard — Lyon, France (Recruiting)
Study contacts
- Principal investigator: Pauline Boucheron, MD — International Agency for Research on Cancer
- Study coordinator: Pauline Boucheron, MD
- Email: boucheronp@iarc.fr
- Phone: +33472738463
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.